Jiangsu Nhwa Pharmaceutical Corp Ltd (002262)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Jiangsu Nhwa Pharmaceutical Corp Ltd (002262) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013629
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jiangsu Nhwa Pharmaceutical Corp Ltd (Jiangsu) is a pharmaceutical company that research, develops and manufactures central nervous system medicines. The company offers psychiatrical, anesthetic and neurological medicines including anti-anxiety agent, anti-psychopathic drug, antiepileptic drug, anti-depressant, hypnotic, intravenous anesthetics and respiratory excitant. Its products are used in treating analgesics, depression, and other diseases. Jiangsu operates through production center, research and development center, marketing center, manufacturing sub-companies and commercial companies. The company offers its products in the dosage forms of tablets, capsules, water injections, powder injections and granules. Jiangsu is headquartered in Xuzhou, China

Jiangsu Nhwa Pharmaceutical Corp Ltd (002262) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Jiangsu Nhwa Pharmaceutical Corp Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Mapi-Pharma Enters Into Partnership Agreement with Jiangsu Nhwa Pharmaceutical 11
Mapi Pharma Enters into Co-Development Agreement with Jiangsu Nhwa Pharma 12
Jiangsu Nhwa Pharma Forms Joint Venture With KF Trading 13
Licensing Agreements 14
Jiangsu Nhwa Pharma Enters into Licensing Agreement with Zysis 14
Jiangsu Nhwa Pharma Enters into Licensing Agreement with NuvOx Pharma 15
D-Pharm Enters Into Licensing Agreement With Jiangsu NHWA Pharma For DP-VPA 16
Equity Offering 17
Jiangsu Nhwa Pharma to Invest Funds in Mapi Pharma 17
Jiangsu Nhwa Pharma to Raise USD90 Million in Private Placement of Shares 18
Jiangsu Nhwa Pharmaceutical Corp Ltd – Key Competitors 19
Jiangsu Nhwa Pharmaceutical Corp Ltd – Key Employees 20
Jiangsu Nhwa Pharmaceutical Corp Ltd – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Jiangsu Nhwa Pharmaceutical Corp Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Jiangsu Nhwa Pharmaceutical Corp Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Jiangsu Nhwa Pharmaceutical Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mapi-Pharma Enters Into Partnership Agreement with Jiangsu Nhwa Pharmaceutical 11
Mapi Pharma Enters into Co-Development Agreement with Jiangsu Nhwa Pharma 12
Jiangsu Nhwa Pharma Forms Joint Venture With KF Trading 13
Jiangsu Nhwa Pharma Enters into Licensing Agreement with Zysis 14
Jiangsu Nhwa Pharma Enters into Licensing Agreement with NuvOx Pharma 15
D-Pharm Enters Into Licensing Agreement With Jiangsu NHWA Pharma For DP-VPA 16
Jiangsu Nhwa Pharma to Invest Funds in Mapi Pharma 17
Jiangsu Nhwa Pharma to Raise USD90 Million in Private Placement of Shares 18
Jiangsu Nhwa Pharmaceutical Corp Ltd, Key Competitors 19
Jiangsu Nhwa Pharmaceutical Corp Ltd, Key Employees 20

★海外企業調査レポート[Jiangsu Nhwa Pharmaceutical Corp Ltd (002262)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Denso Corporation:企業の戦略・SWOT・財務分析
    Denso Corporation - Strategy, SWOT and Corporate Finance Report Summary Denso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Orascom Construction Plc (OC):企業の財務・戦略的SWOT分析
    Orascom Construction Plc (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NxStage Medical Inc (NXTM):企業の財務・戦略的SWOT分析
    NxStage Medical Inc (NXTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ACWA Power International:電力:M&Aディール及び事業提携情報
    Summary ACWA Power International (ACWA Power), a subsidiary of ACWA Holding is a power generation company that develops and operates power generation and desalinated water production plants. The company holds a generation portfolio of power and desalinated water. Its projects comprise in selecting i …
  • Honshu Chemical Industry Co Ltd (4115):企業の財務・戦略的SWOT分析
    Honshu Chemical Industry Co Ltd (4115) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Ei Group plc:企業の戦略・SWOT・財務情報
    Ei Group plc - Strategy, SWOT and Corporate Finance Report Summary Ei Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cineplex Inc:企業の戦略・SWOT・財務情報
    Cineplex Inc - Strategy, SWOT and Corporate Finance Report Summary Cineplex Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Vygon SA-医療機器分野:企業M&A・提携分析
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular a …
  • JenaValve Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary JenaValve Technology Inc (JenaValve Technology), a subsidiary of JenaValve Technology GmbH, is a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. The company’s TAVR system is an investig …
  • Semperit AG Holding (SEM):企業の財務・戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a developer, manufacturer and marketer of rubber products for the medical and industrial sectors. The company’s products include surgical gloves, examination gloves, disposable protective gloves and reusable protective gloves. It also offers hydraulic hoses, …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務分析
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務情報
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Zh International Holdings Ltd
    Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zh International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Genmab AS (GMAB):企業の財務・戦略的SWOT分析
    Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Canadian Pacific Railway Limited (CP):企業の財務・戦略的SWOT分析
    Canadian Pacific Railway Limited (CP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ganymed Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Ganymed Pharmaceuticals AG (Ganymed) is a biopharmaceutical company that manufactures and distributes monoclonal antibodies for the treatment of solid cancers. The company conducts clinical trials to manufacture various drug candidates. It also offers antibody cancer drugs and IMABS for mono …
  • The Home Depot, Inc.:企業のM&A・事業提携・投資動向
    The Home Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Home Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆